Search research articles
Contact Us
Filters
Showing results (281-290 of 310) with videos related to
Page
of 31
Sort By:
The Journal of Clinical Investigation
|
March 1, 1983
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man
G A FitzGerald, J A Oates, J Hawiger, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
February 1, 1988
Effects of thromboxane synthase inhibitors on renal function
E K Jackson, F Goto, H D Uderman, et al.
British Journal of Clinical Pharmacology
|
November 1, 1993
Biopharmaceutical characterisation of a low-dose (75 mg) controlled-release aspirin formulation
W N Charman, S A Charman, D C Monkhouse, et al.
The Journal of Clinical Investigation
|
October 23, 1997
Localization of distinct F2-isoprostanes in human atherosclerotic lesions
D Praticò, L Iuliano, A Mauriello, et al.
The American Review of Respiratory Disease
|
January 1, 1989
Allergen-stimulated release of mediators into sheep bronchoalveolar lavage fluid. Effect of cyclooxygenase inhibition
R Dworski, J R Sheller, N E Wickersham, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 22, 2011
Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus
G E Serrano, N Lelutiu, A Rojas, et al.
Circulation
|
February 18, 1997
Platelet activation by superoxide anion and hydroxyl radicals intrinsically generated by platelets that had undergone anoxia and then reoxygenated
R Leo, D Praticò, L Iuliano, et al.
Blood
|
May 9, 2001
Effect of the Pl(A2) alloantigen on the function of beta(3)-integrins in platelets
J S Bennett, F Catella-Lawson, A R Rut, et al.
Circulation
|
December 22, 1998
Increased formation of distinct F2 isoprostanes in hypercholesterolemia
M P Reilly, D Praticò, N Delanty, et al.
Circulation
|
June 22, 2000
Cardiovascular responses to the isoprostanes iPF(2alpha)-III and iPE(2)-III are mediated via the thromboxane A(2) receptor in vivo
L P Audoly, B Rocca, J E Fabre, et al.
Page
of 31
Search research articles
Search
Showing results (281-290 of 310) with videos related to
Sort By:
Page
of 31
The Journal of Clinical Investigation
|
March 1, 1983
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man
G A FitzGerald, J A Oates, J Hawiger, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
February 1, 1988
Effects of thromboxane synthase inhibitors on renal function
E K Jackson, F Goto, H D Uderman, et al.
British Journal of Clinical Pharmacology
|
November 1, 1993
Biopharmaceutical characterisation of a low-dose (75 mg) controlled-release aspirin formulation
W N Charman, S A Charman, D C Monkhouse, et al.
The Journal of Clinical Investigation
|
October 23, 1997
Localization of distinct F2-isoprostanes in human atherosclerotic lesions
D Praticò, L Iuliano, A Mauriello, et al.
The American Review of Respiratory Disease
|
January 1, 1989
Allergen-stimulated release of mediators into sheep bronchoalveolar lavage fluid. Effect of cyclooxygenase inhibition
R Dworski, J R Sheller, N E Wickersham, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 22, 2011
Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus
G E Serrano, N Lelutiu, A Rojas, et al.
Circulation
|
February 18, 1997
Platelet activation by superoxide anion and hydroxyl radicals intrinsically generated by platelets that had undergone anoxia and then reoxygenated
R Leo, D Praticò, L Iuliano, et al.
Blood
|
May 9, 2001
Effect of the Pl(A2) alloantigen on the function of beta(3)-integrins in platelets
J S Bennett, F Catella-Lawson, A R Rut, et al.
Circulation
|
December 22, 1998
Increased formation of distinct F2 isoprostanes in hypercholesterolemia
M P Reilly, D Praticò, N Delanty, et al.
Circulation
|
June 22, 2000
Cardiovascular responses to the isoprostanes iPF(2alpha)-III and iPE(2)-III are mediated via the thromboxane A(2) receptor in vivo
L P Audoly, B Rocca, J E Fabre, et al.
Page
of 31